References
- Abell M R, Hart W R, Olson J R. Tumors of the peripheral nervous system. Hum Pathol 1970; 1: 503–51
- Harkin J C. Pathology of nerve sheath tumors. Ann NY Acad Sci 1986; 48: 147–54
- Woodruff J M, Godwin T A, Erlanson R A, Susin M, Martini N. Cellular schwannoma: A variety of schwannoma sometimes mistaken for a malignant tumor. Am J Surg Pathol 1981; 5: 733–44
- Fletcher C D, Davies S E, McKee P H. Cellular schwannoma: A distinct pseudosarcomatous entity. Histopathology 1987; 11: 21–35
- Ducatman B S, Scheithauer B W, Piepgras D G, Reiman H M, Ilstrup D M. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986; 57: 2006–21
- Coffin C M, Dehner L P. Peripheral neurogenic tumors of the soft tissues in children and adolescents. A clinicopathologic study of 139 cases. Pediatr Pathol 1989; 9: 387–407
- Coffin C M, Dehner L P. Soft tissue neoplasms in childhood and adolescence. A clinicopathologic review of 944 cases (abstract). Lab Invest 1986; 54: 12A
- Hsu S, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–80
- Wick M R, Swanson P E, Scheithauer B W, Manivel J C. Malignant peripheral nerve sheath tumor. An immunohistochemical study of 62 cases. Am J Clin Pathol 1987; 87: 425–33
- Enzinger F M, Weiss S W. Soft Tissue Tumors2nd ed. Mosby, St Louis 1988; 735–40
- Huvos A G. The spontaneous transformation of benign into malignant soft tissue tumors (with emphasis on extraskeletal osseous, lipomatous, and schwannian lesions). Am J Surg Pathol 1985; 9: S7–20
- Horalc E, Szentirmay Z, Sugar J. Pathologic features of nerve sheath tumors with respect to prognostic signs. Cancer 1983; 51: 1159–67
- Schneider M, Obringer A C, Zackai E, Meadows A T. Childhood neurofibromatosis: Risk factors for malignant disease. Cancer Genet Cytogenet 1986; 21: 347–54
- Sorensen S A, Mulvihill J J, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. N Engl J Med 1986; 314: 1010–15
- Herrera G A, de Moraes H P. Neurogenic sarcomas in patients with neurofibromatosis (von Recklinghausen's disease). Light, electron microscopy a immunohistochemistry study. Virchows Arch ‘A’ 1984; 403: 361–76
- Ackerman L V, Taylor F H. Neurogenous tumors within the thorax. A clinicopathological evaluation of forty-eight cases. Cancer 1951; 4: 669–91
- Ellis P S, Whitehead R. Mitosis counting—a need for reappraisal. Hum Pathol 1981; 12: 3–4
- Trojanowski J Q, Kleinman G M, Proppe K H. Malignant tumors of nerve sheath origin. Cancer 1980; 46: 1202–12
- Guccion J G, Enzinger F M. Malignant schwannoma associated with von Recklinghausen's neurofibromatosis. Virchows Arch (Pathol Anat) 1979; 383: 43–57
- Gould V E, Moll R, Moll I, Lee I, Schwechheimer K, Franke W W. The intermediate filament complement of the spectrum of nerve sheath neoplasms. Lab Invest 1986; 55: 463–74
- Weiss S W, Langloss J M, Enzinger F M. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant schwann cell tumors. Lab Invest 1983; 49: 299–308
- Clark H B, Minesky J J, Agrawal D, Agrawal H C. Myelin basic protein and P2 protein are not immunohistochemical markers for schwann cell neoplasms. A comparative study using antisera to S-100, P2, and myelin basic proteins. Am J Pathol 1985; 121: 96–101